| Title | Type | SJR |
H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Current Molecular Medicine | journal | 1.710 Q1 | 88 | 66 | 116 | 8209 | 414 | 110 | 3.76 | 124.38 | ![]() |
| 2 | Current Medicinal Chemistry | journal | 1.545 Q1 | 144 | 195 | 342 | 21208 | 1621 | 319 | 4.57 | 108.76 | ![]() |
| 3 | Current Pharmaceutical Design | journal | 1.346 Q1 | 128 | 250 | 435 | 24435 | 1976 | 371 | 5.90 | 97.74 | ![]() |
| 4 | Current Drug Metabolism | journal | 1.325 Q1 | 89 | 38 | 89 | 4033 | 378 | 82 | 4.56 | 106.13 | ![]() |
| 5 | Current Topics in Medicinal Chemistry | journal | 1.245 Q1 | 97 | 101 | 122 | 9961 | 526 | 122 | 4.31 | 98.62 | ![]() |
| 6 | Current Drug Targets | journal | 1.237 Q1 | 86 | 64 | 90 | 6210 | 300 | 83 | 3.39 | 97.03 | ![]() |
| 7 | Current Organic Chemistry | journal | 1.233 Q1 | 91 | 94 | 194 | 11166 | 410 | 169 | 2.51 | 118.79 | ![]() |
| 8 | Current Gene Therapy | journal | 1.083 Q1 | 60 | 40 | 58 | 4126 | 230 | 58 | 3.97 | 103.15 | ![]() |
| 9 | Current Cancer Drug Targets | journal | 1.082 Q1 | 79 | 41 | 36 | 3957 | 132 | 36 | 3.67 | 96.51 | ![]() |
| 10 | Current Protein and Peptide Science | journal | 0.947 Q2 | 67 | 42 | 98 | 3574 | 180 | 90 | 1.80 | 85.10 | ![]() |
| 11 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.892 Q1 | 78 | 41 | 57 | 4139 | 138 | 55 | 2.51 | 100.95 | ![]() |
| 12 | Current Pharmaceutical Biotechnology | journal | 0.710 Q1 | 66 | 39 | 80 | 4027 | 188 | 74 | 2.51 | 103.26 | ![]() |
| 13 | CNS and Neurological Disorders - Drug Targets | journal | 0.688 Q1 | 75 | 39 | 43 | 5178 | 81 | 43 | 1.88 | 132.77 | ![]() |
| 14 | Infectious Disorders - Drug Targets | journal | 0.657 Q2 | 45 | 34 | 59 | 3847 | 118 | 55 | 2.15 | 113.15 | ![]() |
| 15 | Combinatorial Chemistry and High Throughput Screening | journal | 0.650 Q1 | 56 | 76 | 176 | 3924 | 403 | 160 | 2.69 | 51.63 | ![]() |
| 16 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.573 Q2 | 41 | 27 | 45 | 2826 | 75 | 45 | 1.67 | 104.67 | ![]() |
| 17 | Mini-Reviews in Medicinal Chemistry | journal | 0.550 Q1 | 72 | 74 | 89 | 5792 | 171 | 89 | 1.92 | 78.27 | ![]() |
| 18 | Current Genomics | journal | 0.317 Q4 | 46 | 51 | 104 | 5104 | 56 | 97 | 0.64 | 100.08 | ![]() |
| 19 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.294 Q3 | 27 | 30 | 18 | 4054 | 17 | 16 | 1.06 | 135.13 | ![]() |
| 20 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.286 Q3 | 35 | 22 | 19 | 2881 | 13 | 17 | 0.76 | 130.95 | ![]() |
| 21 | Protein and Peptide Letters | journal | 0.228 Q4 | 47 | 75 | 196 | 1756 | 84 | 196 | 0.42 | 23.41 | ![]() |
| 22 | Inflammation and Allergy - Drug Targets | journal | 0.160 Q2 | 56 | 27 | 26 | 2956 | 7 | 26 | 0.27 | 109.48 | ![]() |
| 23 | International Journal of Diabetes and Metabolism | journal | 0.120 Q3 | 13 | 8 | 24 | 235 | 1 | 20 | 0.05 | 29.38 | ![]() |
| 24 | Emirates Journal of Food and Agriculture | journal | 0.101 Q4 | 16 | 14 | 24 | 446 | 0 | 24 | 0.00 | 31.86 | ![]() |
| 25 | Emirates Medical Journal | journal | 0.101 Q4 | 4 | 55 | 30 | 1076 | 0 | 25 | 0.00 | 19.56 | ![]() |
Powered by:
Follow us on Twitter
Scimago Lab, Copyright 2007-2017. Data Source: Scopus®